Passage Bio Inc
NASDAQ:PASG

Watchlist Manager
Passage Bio Inc Logo
Passage Bio Inc
NASDAQ:PASG
Watchlist
Price: 9.795 USD -8.29% Market Closed
Market Cap: 30.6m USD

Wall Street
Price Targets

PASG Price Targets Summary
Passage Bio Inc

Wall Street analysts forecast PASG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PASG is 40.392 USD with a low forecast of 10.1 USD and a high forecast of 71.4 USD.

Lowest
Price Target
10.1 USD
3% Upside
Average
Price Target
40.392 USD
312% Upside
Highest
Price Target
71.4 USD
629% Upside
Passage Bio Inc Competitors:
Price Targets
ALDX
Aldeyra Therapeutics Inc
117% Upside
PHIL
Philogen SpA
14% Upside
688428
InnoCare Pharma Ltd
59% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
24% Upside
ONCO
Oncopeptides AB
2% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
56% Upside
DTIL
Precision BioSciences Inc
564% Upside
XFOR
X4 Pharmaceuticals Inc
109% Upside

Revenue
Forecast

Revenue Estimate
Passage Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Passage Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Passage Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PASG's stock price target?
Price Target
40.392 USD

According to Wall Street analysts, the average 1-year price target for PASG is 40.392 USD with a low forecast of 10.1 USD and a high forecast of 71.4 USD.

Back to Top